These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2872871)

  • 1. Pharmacotherapy for patients with borderline personality disorder.
    Gunderson JG
    Arch Gen Psychiatry; 1986 Jul; 43(7):698-700. PubMed ID: 2872871
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol.
    Serban G; Siegel S
    Am J Psychiatry; 1984 Nov; 141(11):1455-8. PubMed ID: 6388363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo.
    Soloff PH; George A; Nathan RS; Schulz PM; Ulrich RF; Perel JM
    Arch Gen Psychiatry; 1986 Jul; 43(7):691-7. PubMed ID: 3521532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tranquilizers on borderline and schizotypal patients questioned.
    Rockland LH
    Am J Psychiatry; 1985 May; 142(5):665-6. PubMed ID: 3885764
    [No Abstract]   [Full Text] [Related]  

  • 5. Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo.
    Goldberg SC; Schulz SC; Schulz PM; Resnick RJ; Hamer RM; Friedel RO
    Arch Gen Psychiatry; 1986 Jul; 43(7):680-6. PubMed ID: 3521531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response.
    Soloff PH; George A; Nathan S; Schulz PM; Cornelius JR; Herring J; Perel JM
    J Clin Psychopharmacol; 1989 Aug; 9(4):238-46. PubMed ID: 2768542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical effects of amitriptyline on borderline patients.
    Soloff PH; George A; Nathan RS; Schulz PM; Perel JM
    Am J Psychiatry; 1986 Dec; 143(12):1603-5. PubMed ID: 3538914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for patients with borderline personality disorder.
    Goldberg SC; Schulz SC
    Arch Gen Psychiatry; 1988 Feb; 45(2):195-6. PubMed ID: 2892479
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug treatment of the personality disorders.
    Stein G
    Br J Psychiatry; 1992 Aug; 161():167-84. PubMed ID: 1355689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open, noncomparative study of amoxapine in borderline disorders.
    Jensen HV; Andersen J
    Acta Psychiatr Scand; 1989 Jan; 79(1):89-93. PubMed ID: 2648768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of the borderline patient: a critical review and clinical guidelines.
    Kutcher SP; Blackwood DH
    Can J Psychiatry; 1989 May; 34(4):347-53. PubMed ID: 2567621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amitriptyline and haloperidol in unstable and schizotypal borderline disorders.
    Soloff PH; George A; Nathan S; Schulz PM; Ulrich RF; Perel JM
    Psychopharmacol Bull; 1986; 22(1):177-82. PubMed ID: 3523575
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychopharmacologic approaches to borderline syndromes.
    Ellison JM; Adler DA
    Compr Psychiatry; 1984; 25(3):255-62. PubMed ID: 6145542
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacotherapy of borderline disorders.
    Soloff PH
    Compr Psychiatry; 1981; 22(6):535-43. PubMed ID: 6118234
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical outcome of psychopharmacologic treatment of borderline and schizotypal personality disordered subjects.
    Coccaro EF
    J Clin Psychiatry; 1998; 59 Suppl 1():30-5; discussion 36-7. PubMed ID: 9448667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The positive effect of alprazolam in the treatment of three patients with borderline personality disorder.
    Faltus FJ
    Am J Psychiatry; 1984 Jun; 141(6):802-3. PubMed ID: 6145360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopharmacology of borderline personality disorder: a review.
    Cowdry RW
    J Clin Psychiatry; 1987 Aug; 48 Suppl():15-25. PubMed ID: 2886493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for personality disorders.
    Hori A
    Psychiatry Clin Neurosci; 1998 Feb; 52(1):13-9. PubMed ID: 9682928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent trends in the pharmacotherapy of personality disorders.
    Markovitz PJ
    J Pers Disord; 2004 Feb; 18(1):90-101. PubMed ID: 15061346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic treatment in the borderline patient: advantages and techniques.
    Soloff PH
    J Clin Psychiatry; 1987 Aug; 48 Suppl():26-31. PubMed ID: 2886494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.